CLOV vs GCTK · rev $1.37B vs P/E 0.1, $4.1M cap
Clover Health Investments Corp (CLOV) versus GlucoTrack Inc (GCTK) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
GCTK does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. GCTK currently screens at market cap $4.1M and trailing P/E 0.1.
Not investment advice. Open the CLOV and GCTK stock pages for the full models.
Not investment advice.